Sterilization & Decontamination Process Validation
Data Integrity and Electronic Logs for Cleaning and Disinfection Activities Data Integrity and Electronic Logs for Cleaning and Disinfection Activities Introduction to Cleaning and Disinfection Validation Cleaning and disinfection validation is a critical component of pharmaceutical manufacturing processes aimed at ensuring the integrity and safety of products. With the evolving regulatory landscape, particularly with guidance documents from organizations such as…
Revalidation Strategies After Sterility Failures in Steam, EO and Radiation Programs The pharmaceutical industry operates under stringent guidelines designed to ensure the safety, efficacy, and quality of medicinal products. Among these, the validation of sterilization processes is critical in preventing sterility failure. Regulatory authorities such as the US FDA and EMA outline specific expectations for validating sterilization methods, including steam,…
Revalidation Strategies After Sterility Failures in Steam, EO and Radiation Programs Introduction to Sterility Failure Investigations Sterility failures represent significant challenges in the pharmaceutical industry, particularly in sterile manufacturing processes such as steam, Ethylene Oxide (EO), and radiation sterilization. A sterility failure investigation is a crucial aspect of the Quality Assurance (QA) lifecycle, aimed at identifying root causes and implementing…
Deviation Management for Sterilisation Cycle Aborts, Alarms and Power Loss Events In pharmaceutical manufacturing, maintaining sterility is paramount to ensuring product quality and safety. When sterilisation cycles experience aborts, alarms, or power failures, it raises significant concerns regarding sterility assurance. This comprehensive tutorial is designed for pharmaceutical and regulatory professionals and will guide you through the process of managing deviations,…
Deviation Management for Sterilisation Cycle Aborts, Alarms and Power Loss Events Deviation Management for Sterilisation Cycle Aborts, Alarms and Power Loss Events In the pharmaceutical industry, maintaining sterility in products is of paramount importance. Understanding how to manage potential deviations such as sterilisation cycle aborts, alarms, and power loss events is crucial. This guide details a step-by-step approach to effectively…
Out-of-Trend Sterility and Bioburden Results – Trending, Triggers and Follow-Up Ensuring product sterility is paramount for maintaining patient safety and meeting regulatory expectations. Any deviations from expected sterility results, referred to as out-of-trend (OOT) results, necessitate thorough investigation and corrective actions. This article aims to discuss the regulatory expectations surrounding sterility failure investigations, including trending, triggers, and follow-up actions in…
Out-of-Trend Sterility and Bioburden Results: Trending, Triggers, and Follow-Up In the pharmaceutical industry, ensuring the sterility of products is paramount, particularly for parenteral and sterile medical devices. Regulatory bodies, including the US FDA, EMA, and MHRA, emphasize rigorous validation protocols that support the assurance of sterility throughout the product lifecycle. This article serves as a comprehensive guide on managing out-of-trend…
Handling Sterility-Related FDA 483s and Warning Letters – Lessons for Validation Teams Handling Sterility-Related FDA 483s and Warning Letters – Lessons for Validation Teams In the pharmaceutical industry, maintaining sterility in products and processes is of paramount importance. Regulatory authorities such as the FDA, EMA, and MHRA monitor compliance with Good Manufacturing Practices (cGMP) to ensure product safety and efficacy….
Managing Media Fill Failures – Investigation, Risk Assessment and CAPA Managing Media Fill Failures – Investigation, Risk Assessment and CAPA Understanding Sterility Failures in the Pharmaceutical Industry Sterility failures within the pharmaceutical manufacturing process represent significant deviations that can compromise product safety, efficacy, and patient health. Regulatory authorities such as the FDA, EMA, and MHRA mandate comprehensive investigations whenever a…
Closing the Loop – CAPA Effectiveness Checks After Sterility-Related CAPAs Closing the Loop – CAPA Effectiveness Checks After Sterility-Related CAPAs In the realm of pharmaceutical manufacturing, addressing sterility failures is of paramount importance due to its direct implications on product quality and patient safety. This regulatory explainer manual will delve into regulatory expectations for effective Corrective and Preventive Actions (CAPA)…